Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7579194

Concept 2022-03-01 to
2022-11-30
2021-03-01 to
2021-11-30
Consolidated statement of income
Statement of income
Net sales
91,881,000,000 JPY
86,663,000,000 JPY
Cost of sales
39,100,000,000 JPY
34,884,000,000 JPY
Operating expenses
Selling, general and administrative expenses
44,274,000,000 JPY
44,805,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
35,000,000 JPY
74,000,000 JPY
Net sales
Gross profit (loss)
52,781,000,000 JPY
51,779,000,000 JPY
Operating profit (loss)
8,506,000,000 JPY
6,973,000,000 JPY
Ordinary profit (loss)
13,003,000,000 JPY
8,665,000,000 JPY
Extraordinary income
142,000,000 JPY
659,000,000 JPY
Gain on disposal of non-current assets
142,000,000 JPY
6,000,000 JPY
Non-operating income
Dividend income
626,000,000 JPY
595,000,000 JPY
Interest income
398,000,000 JPY
110,000,000 JPY
Other
452,000,000 JPY
329,000,000 JPY
Non-operating income
4,687,000,000 JPY
1,927,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
12,000,000 JPY
11,000,000 JPY
Other
46,000,000 JPY
72,000,000 JPY
Non-operating expenses
189,000,000 JPY
235,000,000 JPY
Extraordinary losses
116,000,000 JPY
333,000,000 JPY
Loss on disposal of non-current assets
116,000,000 JPY
53,000,000 JPY
Profit (loss) before income taxes
13,029,000,000 JPY
8,992,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
JPY
652,000,000 JPY
Extraordinary losses
Income taxes
3,208,000,000 JPY
2,564,000,000 JPY
Profit (loss)
9,821,000,000 JPY
6,427,000,000 JPY
Profit (loss) attributable to non-controlling interests
299,000,000 JPY
209,000,000 JPY
Profit (loss) attributable to owners of parent
9,522,000,000 JPY
6,218,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
2,928,000,000 JPY
-1,855,000,000 JPY
Foreign currency translation adjustment
18,021,000,000 JPY
5,013,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-31,000,000 JPY
-42,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-240,000,000 JPY
-193,000,000 JPY
Other comprehensive income
20,678,000,000 JPY
2,922,000,000 JPY
Profit attributable to
Comprehensive income
30,499,000,000 JPY
9,349,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
30,104,000,000 JPY
9,161,000,000 JPY
Comprehensive income attributable to non-controlling interests
395,000,000 JPY
187,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.